Table 1.
Main baseline characteristics of the subjects in the RJ and control group
| RJ | Control | P value | |
|---|---|---|---|
| BMI (kg/m2) |
22.7±0.5 |
22.8±0.5 |
0.9533 |
| Waist circumference (cm) |
86.3±1.3 |
84.1±1.5 |
0.2626 |
| Systolic BP (mmHg) |
135±3 |
137±4 |
0.7135 |
| Diastolic BP (mmHg) |
79±2 |
80±2 |
0.6125 |
| WBC (/μL) |
5090±240 |
5420±280 |
0.3652 |
| RBC (x106/μL) |
4.52±0.08 |
4.64±0.08 |
0.3049 |
| Hb (g/dL) |
14,2±0.3 |
14.5±0.3 |
0.5076 |
| Ht (%) |
44.6±0.7 |
46.0±0.9 |
0.1915 |
| PLT (x103/μL) |
193±11 |
211±10 |
0.2222 |
| log TG (log mg/dL) |
4.79±0.13 |
4.54±0.09 |
0.1128 |
| HDL-C (mg/dL) |
57±3 |
59±3 |
0.5709 |
| LDL-C (mg/dL) |
110±5 |
126±4 |
0.0186 |
| log FPG (log mg/dL) |
4.62±0.03 |
4.63±0.02 |
0.7231 |
| log FIRI (log μIU/mL) |
1.38±0.14 |
1.66±0.11 |
0.1375 |
| log HbA1c (log %) |
1.7±0.0 |
1.7±0.0 |
0.6786 |
| log HOMA-IR |
-0.00±0.16 |
0.29±0.11 |
0.1399 |
| log HOMA-B |
3.66±0.13 |
3.90±0.12 |
0.2009 |
| log IGI |
-0.54±0.18 |
-0.41±0.20 |
0.6309 |
| log DHEA-S (log μg/dL) |
4.22±0.10 |
4.46±0.13 |
0.1541 |
| male |
4.52±0.11 |
4.74±0.13 |
0.2044 |
| female |
3.88±0.20 |
4.07±0.19 |
0.4258 |
| log T (log ng/mL) |
-0.32±0.38 |
0.01±0.41 |
0.5544 |
| male |
1.52±0.05 |
1.68±0.08 |
0.0926 |
| female |
-2.41±0.25 |
-2.27±0.25 |
0.6829 |
| log E2 (log pg/mL) |
2.41±0.14 |
2.74±0.21 |
0.1948 |
| male |
3.11±0.08 |
3.29±0.09 |
0.1138 |
| female |
1.61±0.00 |
1.99±0.38 |
0.3409 |
| log T/DHEAS |
-6.84±0.32 |
-6.74±0.34 |
0.8436 |
| male |
-5.30±0.11 |
-5.35±0.16 |
0.7915 |
| female |
-8.59±0.20 |
-8.64±0.13 |
0.8389 |
| log E2/T |
-4.18±0.26 |
-4.18±0.30 |
0.9994 |
| male |
-5.32±0.08 |
-5.30±0.08 |
0.8960 |
| female |
-2.88±0.25 |
-2.65±0.31 |
0.5678 |
| SF-36 subscale scores | |||
| PF |
81±3 |
89±2 |
0.0393* |
| RP |
84±4 |
88±4 |
0.4342 |
| BP |
66±5 |
69±4 |
0.5467 |
| GH |
61±3 |
63±3 |
0.5936 |
| VT |
61±3 |
67±3 |
0.1529 |
| SF |
88±3 |
94±2 |
0.0922 |
| RE |
91±3 |
91±3 |
0.9693 |
| MH | 71±3 | 80±3 | 0.0289* |
Abbreviations were denoted in the text. * P < 0.05.